"... and yet I haven't seen you provide such warnings to CYP or...

"... and yet I haven't seen you provide such warnings to CYP or Athersys shareholders who have suffered the same fate through the same failures in exactly the same stem cell / biotech sector ?

One could ask why you put so much effort into warning Mesoblast shareholders but not the other 2 examples in the aforementioned paragraphs ? .... enough said "

Your Venn diagram's circle of interest might happen to be "stem cells/biotech"'; mine isn't. Mine is capital adequacy and degree of self sustaining commercialisation.

On that score I comment on a number stocks that I think have warranted caution, including, but not confined to one on which I posted as recently as less than 12 hours ago (had you bothered to check) and another one as recently as a week ago (had you bothered to check). Along with numerous others (again, had you bothered to check) over time.

That those other stocks happen to not form part of the Venn diagram overlap with the universe of stocks you follow is not statistically worthy of comment, because self evidently it would be impossible for any single poster to post on every stock that every other poster follows.

So, demonstrably, it is totally unremarkable that someone should post on a certain ASX stocks, but not on certain other stocks.

But even besides all of the above, a company which has consumed over a billion dollars of capital over the better part of a decade-and-a-half, and yet still remains underfunded without any signs of self sustaining commercialisation in sight?

That is objectively a fascinating story of corporate evolution, so it is unsurprising that it attracts some attention.

.